Bio-Techne Corp. buy melinda
Start price
21.11.17
/
50%
€8.26
Target price
30.11.17
€8.44
Performance (%)
2.23%
End price
30.11.17
€8.45
Summary
This prediction ended on 30.11.17 with a price of €8.45. With a performance of 2.23%, the BUY prediction by melinda for Bio-Techne Corp. closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bio-Techne Corp. | -10.442% | -10.442% | -19.640% | -33.433% |
| iShares Core DAX® | -1.104% | -6.084% | 3.201% | 53.313% |
| iShares Nasdaq 100 | 0.328% | 2.327% | 20.240% | 93.480% |
| iShares Nikkei 225® | -1.082% | -7.987% | 27.550% | 52.317% |
| iShares S&P 500 | -0.055% | 0.880% | 14.887% | 66.737% |
Comments by melinda for this prediction
In the thread Bio-Techne Corp. diskutieren
Bio-Techne Corp. engagiert in der Entwicklung, Herstellung und Verkauf von Biotechnologie Reagenzien und Instrumente für die Forschung und markets.It klinische Diagnose ist in drei Segmente sind: Biotechnologie, Protein-Plattformen, und Diagnostics.